Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer: 17 (AAPS Advances in the Pharmaceutical Sciences Series, 17) - Image 1

£100.49

Springer Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer: 17 (AAPS Advances in the Pharmaceutical Sciences Series, 17)

Name: Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer: 17 (AAPS Advances in the Pharmaceutical Sciences Series, 17)
Brand: Springer
Price: 100.49 GBP
Availability: InStock

Pre-clinical Medicine

It has never been this cheap. We have no record of a lower price.

£100 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 46 days · 46 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 46 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £100 (45 days, 97.8%)

Price range: £100 - £105

Price levels: 2 different prices over 46 days

Description

The field of antibody-drug conjugates (ADCs) has undergone remarkable advancements in recent years, marked by significant progress in both drug approvals and ongoing clinical development. Since the approval of the first ADC in 2010 (gemtuzumab ozogamicin, Mylotarg®), the landscape has expanded dramatically. Today, there are 11 FDA-approved ADCs, targeting a variety of cancers across multiple indications. The approved ADCs include a range of payloads, linkers, and antibodies, each optimized for a variety of specific therapeutic targets. The increasing diversity of ADCs reflects the growing potential of these innovative treatments to address a wide array of malignancies, from hematologic cancers to solid tumors. This book aims to provide a comprehensive overview of the current state of the ADC field including the latest developments, challenges, and emerging trends, comprising expertise from a broad range of disciplines from basic research, industry, clinical practice and regulatory affairs. We explore not only the scientific and technical aspects of ADC design―such as payloads, linkers, and antibody selection―but also the developmental hurdles and regulatory complexities that influence the success of ADCs in clinical practice. Real-world examples of ADCs that have made it from the lab to the clinic offer invaluable insights into the trials and triumphs that shape this dynamic field. It is our hope that this book will serve as both a valuable resource for experts in the field and an accessible introduction for those new to the exciting world of ADCs.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 3031830040
Category: Books > Subjects > Science, Nature & Maths > Medicine > Medical Sciences A-Z > Pre-clinical Medicine
Domain: Amazon UK
Release Date: 16 April 2025
Listed Since: 10 December 2024

Barcode

No barcode data available

Springer Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer: 17 (AAPS Advances in the Pharmaceutical Sciences Series, 17)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Humana Antibody-Drug Conjugates and Immunotoxins Book

A Beginner's Guide to Targeted Cancer Treatments and Cancer Immunotherapy

Innovations for Next-Generation Antibody-Drug Conjugates (Cancer Drug Discovery and Development)

Immunotherapy in Translational Cancer Research (Translational Oncology)

Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)

Cancer Biotherapy: An Introductory Guide

Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)

Critical Developments in Cancer Immunotherapy

Development and Approval of Combination Products: A Regulatory Perspective

Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

Cancer Immunoprevention: Methods and Protocols: 2435 (Methods in Molecular Biology, 2435)

Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Small Molecules for Cancer Treatment

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Small Molecules in Hematology: 212 (Recent Results in Cancer Research, 212)

Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

Springer - Tumor-Induced Immune Suppression Book

Handbook of Targeted Cancer Therapy and Immunotherapy